Is coronary artery bypass grafting still the best strategy? Final 10-year results of the NOBLE trial in unprotected left main coronary artery disease
Prospective, multicentre, randomised clinical trial comparing the long-term outcomes of percutaneous coronary intervention (PCI) with second-generation drug-eluting stents versus coronary artery bypass grafting (CABG) in patients with significant unprotected left main coronary artery stenosis, with long-term all-cause mortality as the primary outcome.